7-114654350-G-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_014491.4(FOXP2):​c.1266+341G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.343 in 151,858 control chromosomes in the GnomAD database, including 10,232 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.34 ( 10232 hom., cov: 32)

Consequence

FOXP2
NM_014491.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 1.39

Publications

14 publications found
Variant links:
Genes affected
FOXP2 (HGNC:13875): (forkhead box P2) This gene encodes a member of the forkhead/winged-helix (FOX) family of transcription factors. It is expressed in fetal and adult brain as well as in several other organs such as the lung and gut. The protein product contains a FOX DNA-binding domain and a large polyglutamine tract and is an evolutionarily conserved transcription factor, which may bind directly to approximately 300 to 400 gene promoters in the human genome to regulate the expression of a variety of genes. This gene is required for proper development of speech and language regions of the brain during embryogenesis, and may be involved in a variety of biological pathways and cascades that may ultimately influence language development. Mutations in this gene cause speech-language disorder 1 (SPCH1), also known as autosomal dominant speech and language disorder with orofacial dyspraxia. Multiple alternative transcripts encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]
FOXP2 Gene-Disease associations (from GenCC):
  • specific language disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • childhood apraxia of speech
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 7-114654350-G-C is Benign according to our data. Variant chr7-114654350-G-C is described in ClinVar as Benign. ClinVar VariationId is 1220788.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.452 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FOXP2NM_014491.4 linkc.1266+341G>C intron_variant Intron 10 of 16 ENST00000350908.9 NP_055306.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FOXP2ENST00000350908.9 linkc.1266+341G>C intron_variant Intron 10 of 16 1 NM_014491.4 ENSP00000265436.7

Frequencies

GnomAD3 genomes
AF:
0.344
AC:
52158
AN:
151740
Hom.:
10236
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.176
Gnomad AMI
AF:
0.380
Gnomad AMR
AF:
0.313
Gnomad ASJ
AF:
0.287
Gnomad EAS
AF:
0.143
Gnomad SAS
AF:
0.313
Gnomad FIN
AF:
0.458
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.456
Gnomad OTH
AF:
0.320
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.343
AC:
52163
AN:
151858
Hom.:
10232
Cov.:
32
AF XY:
0.340
AC XY:
25203
AN XY:
74204
show subpopulations
African (AFR)
AF:
0.176
AC:
7281
AN:
41462
American (AMR)
AF:
0.312
AC:
4764
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.287
AC:
993
AN:
3462
East Asian (EAS)
AF:
0.143
AC:
736
AN:
5156
South Asian (SAS)
AF:
0.314
AC:
1512
AN:
4822
European-Finnish (FIN)
AF:
0.458
AC:
4820
AN:
10514
Middle Eastern (MID)
AF:
0.221
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
0.456
AC:
30979
AN:
67892
Other (OTH)
AF:
0.318
AC:
668
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1657
3315
4972
6630
8287
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
512
1024
1536
2048
2560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.274
Hom.:
812
Bravo
AF:
0.324
Asia WGS
AF:
0.226
AC:
788
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 18, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
14
DANN
Benign
0.73
PhyloP100
1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs936146; hg19: chr7-114294405; API